Antineoplastic Combined Chemotherapy ProtocolsInduction ChemotherapyCyclophosphamideChemotherapy, AdjuvantDoxorubicinCombined Modality TherapyCisplatinTreatment OutcomeDisease-Free SurvivalAntineoplastic AgentsDrug Administration ScheduleVincristineNeutropeniaRemission InductionGranulocyte Colony-Stimulating FactorDose-Response Relationship, DrugNeoadjuvant TherapyEtoposideSurvival AnalysisRadiation DosageNeoplasm StagingSurvival RateRadiation, IonizingCytarabineHead and Neck NeoplasmsLung NeoplasmsCarboplatinPrognosisPaclitaxelTaxoidsRadiation InjuriesCarcinoma, Squamous CellLeukemia, Myeloid, AcuteRadiotherapyIfosfamideDaunorubicinRadiotherapy DosageRadiotherapy, AdjuvantBreast NeoplasmsDose-Response Relationship, RadiationMethotrexateVinblastineNeoplasm Recurrence, LocalCarcinoma, Non-Small-Cell LungBleomycinFluorouracilChemoradiotherapyTime FactorsDeoxycytidineRadiation TolerancePrecursor Cell Lymphoblastic Leukemia-LymphomaFollow-Up StudiesTransplantation, AutologousSalvage TherapyRadiationAntimetabolites, AntineoplasticEnzyme InductionDose FractionationKaplan-Meier EstimateIdarubicinDrug Resistance, NeoplasmLeukemia, MyeloidRadiation MonitoringProspective StudiesLaryngectomyHypopharyngeal NeoplasmsTesticular NeoplasmsOrganoplatinum CompoundsRadiation ProtectionMelphalanNasopharyngeal NeoplasmsNeoplasmsNeoplasm MetastasisCranial IrradiationAdenocarcinomaAnthracyclinesMitoxantroneHematopoietic Stem Cell TransplantationRadiotherapy, High-EnergyLymphoma, Non-HodgkinNeoplasms, Germ Cell and EmbryonalAntineoplastic Agents, PhytogenicRecurrenceVindesineMucositisClinical Trials as TopicThiotepaAsparaginaseLaryngeal NeoplasmsLeukopeniaBrain NeoplasmsCamptothecinGerminomaInfusions, IntravenousAntibiotics, AntineoplasticBone NeoplasmsLymphatic MetastasisFeasibility StudiesAntineoplastic Agents, AlkylatingNeoplasm, Residual